The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CONNECT BIOPHARMA HLDGS LTD SHS G23549101   1,153,061 408,887 SH   SOLE   0 0 408,887
ACLARIS THERAPEUTICS INC COM 00461U105   42,892,500 14,250,000 SH   SOLE   0 0 14,250,000
ATEA PHARMACEUTICALS INC COM 04683R106   26,739,300 7,490,000 SH   SOLE   0 0 7,490,000
LISATA THERAPEUTICS INC COM 128058302   136,427 73,348 SH   SOLE   0 0 73,348
CARMAX INC COM 143130102   5,989,200 155,000 SH   SOLE   0 0 155,000
CARVANA CO CL A 146869102   2,016,000 150 SH Put SOLE   0 0 150
IMAGENEBIO INC COM 45175G207   1,221,479 177,026 SH   SOLE   0 0 177,026
INSTIL BIO INC COM NEW 45783C200   7,101,600 645,600 SH   SOLE   0 0 645,600
KEZAR LIFE SCIENCES INC COM NEW 49372L209   4,533,750 720,787 SH   SOLE   0 0 720,787
ORAMED PHARMACEUTICALS INC COM NEW 68403P203   9,026,608 3,167,231 SH   SOLE   0 0 3,167,231
OUTSET MED INC COM NEW 690145206   2,015,198 543,180 SH   SOLE   0 0 543,180
PMV PHARMACEUTICALS INC COM 69353Y103   6,615,000 5,292,000 SH   SOLE   0 0 5,292,000
PLIANT THERAPEUTICS INC COM 729139105   1,886,287 1,546,137 SH   SOLE   0 0 1,546,137
TARGET CORP COM 87612E106   3,665,625 37,500 SH   SOLE   0 0 37,500
TESLA INC COM 88160R101   205,000 1,000 SH Put SOLE   0 0 1,000
WALMART INC COM 931142103   492,450 335 SH Put SOLE   0 0 335